Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium bicarbonate for vasopressor-dependent ICU patients with moderate metabolic acidosis
ACTRN12620001361998Phase 2Terminated
- Sponsor
- Australian and New Zealand Intensive Care Research Centre
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, randomised, open-label trial of sodium bicarbonate in metabolic acidosis, sponsored by Australian and New Zealand Intensive Care Research Centre. Primary endpoint: Hours alive and free of vasopressors at day 7. Started Jun 2021; status: terminated.
02
Drugs
sodium bicarbonate
03
Conditions
metabolic acidosis
Beyond the preview
Go deeper on ACTRN12620001361998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620001361998.